Stock Market News

Dyne Therapeutics stock rises on orphan drug status

Apr 24, 2025 - 14:55
 0
Dyne Therapeutics stock rises on orphan drug status
Read More

Tags:

Previous Article

PepsiCo cuts annual profit forecast as tariffs set to drive up costs

Next Article

WW International stock falls amid bankruptcy preparations

Related Posts

US Supreme Court poised to revive challenge to California emissions standards

US Supreme Court poised to revive challenge to Californ...

Apr 23, 2025  0

US Supreme Court rebuffs CSX bid to revive antitrust suit against Norfolk Southern

US Supreme Court rebuffs CSX bid to revive antitrust su...

Apr 21, 2025  0

Analysis-Google, X next targets as Europe stays tough on tech regulation

Analysis-Google, X next targets as Europe stays tough o...

Apr 23, 2025  0